This is a working overview of NR1D2, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-05-30 and is reviewed periodically as new material appears.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
| Property | Value | Notes |
|---|---|---|
| Appearance | Off-white to pale yellow solid | Visual description varies with purity and source |
| Solubility | Soluble in DMSO and ethanol; poorly soluble in water | Organic stock solutions are common in research |
| Typical storage | -20 °C, desiccated, protected from light | Avoid repeated freeze-thaw cycles |
| Typical analytical method | LC-MS or HPLC-UV | Reference standards are needed for quantification |
| Molar mass | Approximately 437.9 g/mol | Calculated from the reported free-base formula |
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
He looked pale, delicate and shaky, not his usual robust self: "He was very ill when he got here." After being taken by Reitell to check in at the Chelsea Hotel, Thomas took the first rehearsal of Under Milk Wood. They then went to the White Horse Tavern in Greenwich Village, before returning to the Chelsea Hotel. The next day, Reitell invited him to her apartment, but he declined. They went sightseeing, but Thomas felt unwell and retired to his bed for the rest of the afternoon. Reitell gave him half a grain (32.4 milligrams) of phenobarbitone to help him sleep and spent the night at the hotel with him. Two days later, on 23 October, at the third rehearsal, Thomas said he was too ill to take part, but he struggled on, shivering and burning with fever, before collapsing on the stage. The following day, 24 October, Reitell took Thomas to see her doctor, Milton Feltenstein, who administered cortisone injections and Thomas made it through the first performance that evening, but collapsed immediately afterwards. "This circus out there," he told a friend who had come back-stage, "has taken the life out of me for now." Reitell later said that Feltenstein was "rather a wild doctor who thought injections would cure anything."
=== Planned/unfinished designs === Focke-Wulf Fw 42 – twin-engined medium bomber project developed from the F 19, 1933. Focke-Wulf Ta 183 Huckebein – design for a jet-engined fighter, 1942. Focke-Wulf Fw 206 – planned commercial aircraft, 1940. Focke-Wulf Fw 238 – long-range bomber project (RLM airframe number 8-238 already used by Blohm und Voss) Focke-Wulf Fw 249 – large transport aircraft project; officially designated as Project 195. Focke-Wulf Fw 250 – twin-engine jet fighter project Focke-Wulf Fw 252 – single engine jet fighter Focke-Wulf Ta 254 – proposed version of the Ta 154 fighter. Focke-Wulf Fw 259 Frontjäger (concept) Focke-Wulf Fw 260 – 1960s VTOL airliner proposal Focke-Wulf Fw 261 – four-engine bomber/reconnaissance/U-boat support aircraft project Focke-Wulf Ta 283 – interceptor fighter project Focke-Wulf Fw 300 – proposed long-range version of Fw 200, 1941-1942. Focke-Wulf Ta 400 – Amerikabomber design competitor, never built, 1943. Focke-Wulf Fw P.03.10206 – series of long-range strategic bomber projects, 1944. Focke-Wulf Fw P.03.10221-15 – large capacity strategic transport, 1941. Focke-Wulf Fw P.03.10025 – A 1944 design with a swept wing, a forward-swept V-tail, and two pusher propellers at the rear. Focke-Wulf Fw 03.10251 – series of jet-engined night and bad weather fighters Focke-Wulf Fighter Project w/BMW803 – A 1941 design with a connected twin-boom tail, slightly swept-back wings, and two pusher propellers at the rear.
== Further reading == Ballard, Mary, W (1991), IMPORTANT EARLY SYNTHETIC DYES Chemistry Constitution Date Properties, Smithsonian Institution{{citation}}: CS1 maint: multiple names: authors list (link) https://colourlex.com/ Venkataraman, K. (1971). The chemistry of synthetic dyes (Vol. 1, 5). New York: Academic Press.
"No cathedral," he wrote, "can be built if no community desires one." In the summer of 1924 Adorno received his doctorate with a study of Edmund Husserl's phenomenology under the direction of the unorthodox neo-Kantian Hans Cornelius. Before his graduation, Adorno had already met his most important intellectual collaborators, Horkheimer and Benjamin. Adorno met Horkheimer through Cornelius's seminars, and Horkheimer subsequently introduced him to Friedrich Pollock.
== Monitoring glutathione reductase activity == The activity of glutathione reductase is used as indicator for oxidative stress. The activity can be monitored by the NADPH consumption, with absorbance at 340 nm, or the formed GSH can be visualized by Ellman's reagent. Alternatively the activity can be measured using roGFP (redox-sensitive Green Fluorescent Protein).
Sources: en.wikipedia.org
=== United States === The Orphan Drug Act (ODA) of January 1983, passed in the United States, with lobbying from the National Organization for Rare Disorders and many other organizations, is meant to encourage pharmaceutical companies to develop drugs for diseases that have a small market. Under the ODA drugs, vaccines, and diagnostic agents would qualify for orphan status if they were intended to treat a disease affecting fewer than 200,000 American citizens. Under the ODA orphan drug sponsors qualify for seven-year FDA-administered market Orphan Drug Exclusivity (ODE), "tax credits of up to 50% of R&D costs, R&D grants, waived FDA fees, protocol assistance and may get clinical trial tax incentives. In the U.S., orphan drug designation means that the sponsor qualifies for certain benefits, but it does not mean the drug is safe, effective or legal. In 2002, the Rare Diseases Act was signed into law. It amended the Public Health Service Act to establish the Office of Rare Diseases. It also increased funding for the development of treatments for people with rare diseases.
== Analysis of polymers using end groups == Because of the importance of end groups, there have been many analytical techniques developed for the identification of the groups. The three main methods for analyzing the identity of the end group are by NMR, mass spectrometry (MS) or vibrational spectroscopy (IR or Raman). Each technique has its advantages and disadvantages, which are details below.
During the dot-com boom, Webvan, an online-only supermarket, was formed and went bankrupt after three years and was acquired by Amazon. The British online supermarket Ocado, which uses a high degree of automation in its warehouses, was the first successful online-only supermarket. Ocado expanded into providing services to other supermarket firms such as Waitrose and Morrisons. Grocery stores such as Walmart employ food delivery services offered by third parties such as DoorDash. Other online food delivery services, such as Deliveroo in the United Kingdom, have begun to pay specific attention to supermarket delivery. Delivery robots are offered by various companies partnering with supermarkets. Micro-fulfillment centers (MFC) are relatively small warehouses with sophisticated automated rack-and-tote systems which prepare orders for pickup and delivery. Once the order is complete, the customer will pick it up (i.e. "click-and-collect") or have it fulfilled via home delivery. Supermarkets are investing in micro-fulfillment centers with the hope that automation can help reduce the costs of online commerce and e-commerce by shortening the distances from store to home and speeding up deliveries. MFCs are said by many to be the key to profitably fulfilling online orders.
Instantized milk powder – Instant milk powder has become the basis for a variety of new products that are rehydratable. This process increases the surface area of the powdered product by partially rehydrating spray-dried milk powder. Freeze-drying – The first application of freeze drying was most likely in the pharmaceutical industry; however, a successful large-scale industrial application of the process was the development of continuous freeze drying of coffee. High-temperature short time processing – These processes, for the most part, are characterized by rapid heating and cooling, holding for a short time at a relatively high temperature and filling aseptically into sterile containers. Decaffeination of coffee and tea – Decaffeinated coffee and tea was first developed on a commercial basis in Europe around 1900. The process is described in U.S. patent 897,763. Green coffee beans are treated with water, heat and solvents to remove the caffeine from the beans. Process optimization – Food technology now allows production of foods to be more efficient, oil saving technologies are now available on different forms. Production methods and methodology have also become increasingly sophisticated. Aseptic packaging – the process of filling a commercially sterile product into a sterile container and hermetically sealing the containers so that re-infection is prevented. Thus, this results into a shelf stable product at ambient conditions.
== Background == What later became the nation of South Africa was not politically unified in the late nineteenth century. The territory had four distinct entities: the two British colonies of Cape Colony and Natal; and the two Boer republics of the Orange Free State and the South African Republic, more commonly referred to as the Transvaal.
Sources: en.wikipedia.org
Harmonized analyses of measurements from residential buildings have shown substantial variation in indoor CO2 concentrations according to ventilation type and other building and environmental characteristics. Guidelines and standards use CO2 concentrations as an indicator of indoor air quality and ventilation. The National Institute for Occupational Safety and Health (NIOSH) considers concentrations above 1000 ppm to be a marker suggesting inadequate ventilation. Guidance for schools in the United Kingdom has used concentrations of 800 ppm or lower as an indicator of good ventilation. Thresholds used to characterize indoor air quality vary among standards and guidance documents. In occupied, poorly ventilated spaces, CO2 concentrations can rise substantially above outdoor levels within a relatively short period. The rate of increase depends on factors such as room volume, occupancy and ventilation. Measurements in enclosed office spaces have shown that concentrations can rise from approximately 500 ppm to above 1000 ppm within tens of minutes after ventilation is stopped.
The matrix (4) is often referred to as the transfer matrix. It is used to evaluate whether an ion will have stable motion. If the absolute value of the trace of this matrix is less than 2 the ion is said to have stable motion. Stable motion simply means that the secular oscillation of the ion has a maximum displacement. When the absolute value of the trace is greater than 2 ion motion is not stable and the displacement of the ion increases with each secular oscillation. Ion trajectories in a linear or 3D DIT as well as in a digital mass filter, may also be calculated using a similar procedure. Unlike stability calculation it is advantageous for the purpose of resolution and accuracy to represent each period of the waveform with an adequate number of constant voltage steps. The trajectory for the constant potential step,
=== Movement === To mitigate the problem of motion sickness in VR, Valve implemented several movement options. They cited inspiration from the 2018 VR game Budget Cuts, which uses teleporting to move the player between locations. Valve had assumed that teleportation would damage the experience; however, though teleporting appears jarring when watching others use it, they found that players quickly became accustomed to it. According to Walker, "It recedes to the background of your mind, and you become much more focused on what you're doing with it." To disincentivize players from quickly teleporting through levels, Valve filled areas with elements to capture their attention and slow them down, such as threats, collectables, set pieces, or other points of interest. To solve the problem of taller players having to crouch when moving through some spaces, Valve standardized the player's virtual body size when they teleport, effectively making every player the same height when teleporting. They found that players did not notice this discrepancy as they were focused on moving to their goal.
A parathyroid adenoma is the most common cause of hyperparathyroidism. They are more commonly found in women than in men. In this form, the chief cells mutate to exhibit multiple nuclei. Chief cells in parathyroid adenomas also display acid phosphatase activity. It is a benign tumor of the gland that requires surgical removal. These benign adenomas are typically affect only one or two of the parathyroid glands, known respectively as a single adenoma or double adenoma. Typically, no disease is linked to the cause. A primary adenoma can only develop as a primary cause.
Sources: en.wikipedia.org
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.
The compound is generally handled as light-sensitive and stored cold and dry. Stability in solution depends on solvent, concentration, and storage time. Specific degradation rates are not fully standardized.
Limited water solubility affects formulation for cell and animal studies. Organic co-solvents are often used to dissolve it. Precipitation can confound assay results if not controlled.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.